About Vasculitis

Cogan's Syndrome

Download this page as a PDF

What is Cogan's Syndrome?

Cogan's Syndrome is a rare inflammatory disease characterised by inflammation of the inner ears and eyes. It can lead to vision difficulties, hearing loss and dizziness. Commonly there is also inflammation in other organs as well, particularly the heart and large blood vessels, nervous system and bowels.

Who are affected?

Although any age can be affected the syndrome is commonest in young adults (20's and 30's). It affects males and females equally.

What is the aetiology (cause)?

The cause of Cogan's Syndrome is not yet known.

What are the symptoms?

The most common symptoms include red, painful, light-sensitive or blurred vision; hearing loss (which may become profound and permanent); vertigo (dizziness); poor balance; nausea and vomiting; fever, fatigue and weight loss.

Cogan's Syndrome

Making a diagnosis

There are no specific diagnostic tests. The diagnosis is made on clinical examination and history where a combination of problems in the eyes and inner ears are described. Other infections/diseases, including Wegener's Granulomatosis and Rheumatoid Arthritis need to be excluded.


There are no clinical trials of treatment in Cogan's Syndrome. Most people with Cogan's Syndrome will need treatment with moderately high doses of prednisolone or other types of steroids. A few patients with very mild eye disease may be treated with anti-inflammatory drugs including steroids and nonsteroidal anti-inflammatory drugs (NSAIDs) which are applied to the eye. Many patients will also require additional treatment with other immunosuppressive drugs including Methotrexate, Ciclosporin, Azathioprine, Tacrolimus or Cyclophosphamide.

Drugs and Side effects

For information on the main drugs prescribed for Cogan's Syndrome see:

For information on other drugs used in the treatment of vasculitis see Glossary of drugs and side effects.


The course of the disease varies significantly from patient to patient. In some patients there is an initial flare, which may last several weeks to months. Following this there may be a slowly progressive course in some patients while others have a course of complete remission with intermittent episodes of disease activity. Fortunately blindness occurs in less than five per cent of patients. Deafness is a frequent and debilitating outcome occurring in up to 54 per cent of patients.

Key Points

  • Cogan's Syndrome commonly affects the eyes and ears causing vision, hearing and balance problems
  • Treatment will depend on the disease severity

Related Vasculitis Articles

Further reading

eurordis logo


Bio Behçet’s Trial

08 Mar 2018

New trial announced

RAIRDA - Launch New Report on Rare Disease Day

08 Mar 2018

New report for Rare Disease Day

Vasculitis UK AGM

07 Mar 2018

A date for your diary


North West Support Group Meeting

17 Mar 2018

Joing the Northwest Support Group for a coffee

Canal Canter for VUK

24 Mar 2018

10k run for VUK

Merseyside, Cheshire and North Wales Support Meeting

27 Mar 2018

Lunchtime meeting in Liverpool

Coffee and Chat in Lincoln

07 Apr 2018

Meeting of Lincoln Vasculitis Support Group

Three Lochs Way

07 Apr 2018

34 Mile challenge for VUK

Copyright © 2018 Vasculitis UK. All Rights Reserved. Whilst we make every effort to keep up to date, any information that is provided by Vasculitis UK should not be a substitute for professional medical advice. Always seek the opinion of your GP or other qualified medical professional before starting any new treatment, or making changes to existing treatment.
Design & Hosting by On Screen